X. Wang

583 total citations
28 papers, 428 citations indexed

About

X. Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, X. Wang has authored 28 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in X. Wang's work include CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Melanoma and MAPK Pathways (3 papers). X. Wang is often cited by papers focused on CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Melanoma and MAPK Pathways (3 papers). X. Wang collaborates with scholars based in China, United States and Ethiopia. X. Wang's co-authors include Paul Geha, Judith A. Paice, R. Norman Harden, A. Vania Apkarian, Rongqiao He, Jane Y. Wu, Kan Liu, Weichuan Mo, Ying Liu and R. Prins and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and The Journal of Physical Chemistry B.

In The Last Decade

X. Wang

26 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
X. Wang China 9 145 128 91 72 70 28 428
Wojciech Ścierski Poland 12 227 1.6× 97 0.8× 90 1.0× 137 1.9× 59 0.8× 86 567
Arif Şanlı Türkiye 9 53 0.4× 21 0.2× 52 0.6× 96 1.3× 22 0.3× 32 350
Monika Adt Germany 8 103 0.7× 123 1.0× 104 1.1× 55 0.8× 16 0.2× 11 473
Nils Rosshirt Germany 13 40 0.3× 39 0.3× 102 1.1× 71 1.0× 44 0.6× 17 589
Hyo Jin Chung South Korea 13 155 1.1× 48 0.4× 41 0.5× 187 2.6× 7 0.1× 32 479
Christopher P. Geffre United States 8 79 0.5× 21 0.2× 74 0.8× 106 1.5× 21 0.3× 10 333
Karolina Przybyłowska-Sygut Poland 13 37 0.3× 19 0.1× 201 2.2× 21 0.3× 69 1.0× 29 388
Ping Guo China 14 39 0.3× 19 0.1× 133 1.5× 26 0.4× 40 0.6× 34 406

Countries citing papers authored by X. Wang

Since Specialization
Citations

This map shows the geographic impact of X. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X. Wang more than expected).

Fields of papers citing papers by X. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by X. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X. Wang. The network helps show where X. Wang may publish in the future.

Co-authorship network of co-authors of X. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of X. Wang. A scholar is included among the top collaborators of X. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with X. Wang. X. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Yang, et al.. (2025). Development and Evaluation of an Innovative S‐Flurbiprofen‐Diethylamine Emulgel With Superior Transdermal Delivery and Analgesic Activity. Journal of Biomedical Materials Research Part A. 113(7). e37936–e37936.
2.
Wang, X., et al.. (2024). Magnesium Depletion Score and Metabolic Syndrome in US Adults: Analysis of NHANES 2003 to 2018. The Journal of Clinical Endocrinology & Metabolism. 109(12). e2324–e2333. 23 indexed citations
3.
4.
Lian, Bin, Nan Wu, Mingzhong Li, et al.. (2023). Phase II clinical trial of neoadjuvant anti-PD-1 (toripalimab) combined with axitinib in resectable mucosal melanoma. Annals of Oncology. 35(2). 211–220. 22 indexed citations
5.
6.
7.
Ying, Zhitao, Yuqin Song, X. Wang, et al.. (2021). A PHASE II STUDY OF ANTI‐PD‐1 SINTILIMAB IN COMBINATION WITH CHIDAMIDE AND AZACITIDINE IN REFRACTORY AND RELAPSED PERIPHERAL T‐CELL LYMPHOMA. Hematological Oncology. 39(S2). 2 indexed citations
8.
Xie, Yun, Lan Mi, Wen Zheng, et al.. (2021). CAMRELIZUMAB COMBINED WITH GEMOX IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA. Hematological Oncology. 39(S2). 1 indexed citations
9.
10.
Wang, X., et al.. (2019). MA10.02 Deep Learning with Radiomics May Predict High-Grade Lung Adenocarcinoma Based on Histological Patterns in Ground Glass Opacity Lesions. Journal of Thoracic Oncology. 14(10). S286–S286. 1 indexed citations
11.
Wang, X., et al.. (2018). MA05.11 Radiomics Analysis Using SVM Predicts Mediastinal Lymph Nodes Status of Squamous Cell Lung Cancer by Pre-Treatment Chest CT Scan. Journal of Thoracic Oncology. 13(10). S374–S374. 4 indexed citations
12.
13.
Wang, X., et al.. (2018). The Significant Role of c-Abl Kinase in Barrier Altering Agonists-mediated Cytoskeletal Biomechanics. Scientific Reports. 8(1). 1002–1002. 5 indexed citations
14.
Si, Lu, X. Zhang, Yongqian Shu, et al.. (2018). KEYNOTE-151: A phase Ib study of second-line pembrolizumab (Pembro) for Chinese patients (pts) with advanced or metastatic melanoma. Annals of Oncology. 29. viii448–viii448. 1 indexed citations
15.
Wang, X., et al.. (2017). Imatinib Alters Agonists-mediated Cytoskeletal Biomechanics in Lung Endothelium. Scientific Reports. 7(1). 14152–14152. 8 indexed citations
16.
Liu, Kan, Ying Liu, Weichuan Mo, et al.. (2010). MiR-124 regulates early neurogenesis in the optic vesicle and forebrain, targeting NeuroD1. Nucleic Acids Research. 39(7). 2869–2879. 78 indexed citations
17.
Liu, Xiaohui, et al.. (2009). Genetic and environmental contributions to allergen sensitization in a Chinese twin study. Clinical & Experimental Allergy. 39(7). 991–998. 51 indexed citations
18.
Geha, Paul, et al.. (2008). Brain dynamics for perception of tactile allodynia (touch-induced pain) in postherpetic neuralgia. Pain. 138(3). 641–656. 78 indexed citations
19.
Tsai, Hui‐Ju, Rajesh Kumar, Jacqueline A. Pongracic, et al.. (2008). Familial aggregation of food allergy and sensitization to food allergens: a family‐based study. Clinical & Experimental Allergy. 39(1). 101–109. 91 indexed citations
20.
Schrag, Deborah, Laura Archer, X. Wang, et al.. (2007). A patterns-of-care study of post-progression treatment (Rx) among patients (pts) with advanced pancreas cancer (APC) after gemcitabine therapy on Cancer and Leukemia Group B (CALGB) study #80303. Journal of Clinical Oncology. 25(18_suppl). 4524–4524. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wojciech Ścierski Breakdown of academic impact, for papers by Arif Şanlı Breakdown of academic impact, for papers by Monika Adt Breakdown of academic impact, for papers by Nils Rosshirt Breakdown of academic impact, for papers by Hyo Jin Chung Breakdown of academic impact, for papers by Christopher P. Geffre Breakdown of academic impact, for papers by Karolina Przybyłowska-Sygut Breakdown of academic impact, for papers by Ping Guo
Rankless by CCL
2026